Manufacturer
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Products listed
- 9
- Molecules
- 3
- Therapy areas
- 1
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 9 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) products through licensed channels, with the documents your regulator needs.
Antibiotics
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| E.e.s 200 mg/5 mL oral suspensionOral | Erythromycin | US FDA | Available on request |
| E.e.s 400 400 mg tabletOral | Erythromycin | US FDA | Available on request |
| Ery-Ped 200 mg/5 mL oral suspensionOral | Erythromycin | US FDA | Available on request |
| Ery-Ped 400 mg/5 mL oral suspensionOral | Erythromycin | US FDA | Available on request |
| Erythromycin 400 mg tabletOralGeneric name | Erythromycin | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Edarbyclor 40 mg/12.5 mg tabletOral | Azilsartan and Chlorthalidone | US FDA | Available on request |
| Edarbyclor 40 mg/25 mg tabletOral | Azilsartan and Chlorthalidone | US FDA | Available on request |
| Horizant 300 mg extended-release tabletOral | Gabapentin enacarbil | US FDA | Available on request |
| Horizant 600 mg extended-release tabletOral | Gabapentin enacarbil | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Send a request for any of these products. We confirm the licensed source, documents and lead time.